985
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report

, , , , , & show all
Pages 81-94 | Received 06 Jul 2016, Accepted 18 Jul 2016, Published online: 01 Sep 2016

References

  • Vessely MB, Whaley AL, Harmsen WS, et al. The Chitranjan Ranawat Award: long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res. 2006;452:28–34.
  • Ulrich SD, Seyler TM, Bennett D, et al. Total hip arthroplasties: what are the reasons for revision? Int Orthop. 2008;32:597–604.
  • Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27:302–345.
  • Azzam K, Parvizi J, Jungkind D, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am. 2009;91:142–149.
  • Kao AS, Brandt ME, Pruitt WR, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis. 1999;29:1164–1170.
  • Kamme C, Lindberg L. Aerobic and anaerobic bacteria in deep infections after total hip arthroplasty: differential diagnosis between infectious and non-infectious loosening. Clin Orthop Relat Res. 1981;154:201–207.
  • MacGregor RR, Schimmer BM, Steinberg ME. Results of combined amphotericin B-5-fluorcytosine therapy for prosthetic knee joint infected with Candida parapsilosis. J Rheumatol. 1979;6:451–455.
  • Hwang BH, Yoon JY, Nam CH, et al. Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br. 2012;94:656–659.
  • Ueng SWN, Lee CY, Hu CC, et al. What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res. 2013;471:3002–3009.
  • Deelstra JJ, Neut D, Jutte PC. Successful treatment of Candida albicans-infected total hip prosthesis with staged procedure using and antifungal-loaded cement spacer. J Arthroplasty. 2013;28:374.e5–e378.
  • Hall RL, Frost RM, Vasukutty NL, et al. Candida glabrata: an unusual fungal infection following a total hip replacement. BMJ Case Reports. 2012;2012: pii: bcr-2012-006491. doi: 10.1136/bcr-2012-006491.
  • Lerch K, Kalteis T, Schubert T, et al. Prosthetic joint infections with osteomyelitis due to Candida albicans. Mycoses. 2003;46:462–466.
  • Kelesidis T, Tsiodras S. Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option? Scand J Infect Dis. 2010;42:12–21.
  • Graw B, Woolson S, Huddleston JI. Candida infection in total knee arthroplasty with successful reimplantation. J Knee Surg. 2010;23:169–174.
  • Bland CM, Thomas S. Micafungin plus fluconazole in an infected knee with retained hardware due to Candida albicans. Ann Pharmacother. 2009;43:528–531.
  • Gaston G, Ogden J. Candida glabrata periprosthetic infection: a case report and literature review. J Arthroplasty. 2004;19:927–930.
  • Wyman J, McGough R, Limbird R. Fungal infection of a total knee prosthesis: successful treatment using articulating cement spacers and staged reimplantation. Orthopedics. 2002;25:1391–1394.
  • Phelan DM, Osmon DR, Keating MR, et al. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis. 2002;34:930–938.
  • Brooks DH, Pupparo F. Successful salvage of a primary total knee arthroplasty infected with Candida parapsilosis. J Arthroplasty. 1998;13:707–712.
  • Simonian PT, Brause BD, Wickiewicz TL. Candida infection after total knee arthroplasty. Management without resection or amphotericin. Br J Arthroplasty. 1997;12:825–829.
  • Cushing RD, Fulgenzi WR. Synovial fluid levels of fluconazole in a patient with Candida parapsilosis prosthetic joint infection who had an excellent clinical response. J Arthroplasty. 1997;12:950.
  • Hennessy MJ. Infection of a total knee arthroplasty by Candida parapsilosis. A case report of successful treatment by joint reimplantation with a literature review. Am J Knee Surg. 1996;9:133–136.
  • Cardinal E, Braunstein EM, Capello WN, et al. Candida albicans infection of prosthetic joints. Orthopedics. 1996;19:247–251.
  • White A, Goetz MB. Candida parapsilosis prosthetic joint infection unresponsive to treatment with fluconazole. Clin Infect Dis. 1995;20:1068–1069.
  • Tunkel AR, Thomas CY, Wispelway B. Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature. Am J Med. 1993;94:100–103.
  • Evans RP, Nelson CL. Staged reimplantation of a total hip prosthesis after infection with Candida albicans. A report of two cases. J Bone Joint Surg Am. 1990;72:1551–1553.
  • Darouiche RO, Hamill RJ, Musher DM, et al. Periprosthetic candidal infections following arthroplasty. Rev Infect Dis. 1989;11:89–96.
  • Lambertus M, Thodarson D, Goetz MB. Fungal prosthetic arthritis: presentation of two cases and review of the literature. Rev Infect Dis. 1988;10:1038–1043.
  • Levine M, Rehm SJ, Wilde AH. Infection with Candida albicans of a total knee arthroplasty. Case report and review of the literature. Clin Orthop Relat Res. 1988;226:235–239.
  • Iskander MK, Khan MA. Candida albicans infection of a prosthetic knee replacement. J Rheumatol. 1988;15:1594–1595.
  • Koch AE. Candida albicans infection of a prosthetic knee replacement: a report and review of the literature. J Rheumatol. 1988;15:362–365.
  • Lim EVA, Stern PJ. Candida infection after implant arthroplasty. A case report. J Bone Joint Surg Am. 1986;68:143–145.
  • Younkin S, McCollister Evarts C, Steigbidel RT. Candida parapsilosis infection of a total hip-joint replacement: successful reimplantation after treatment with amphotericin B and 5-fluorocytosine. A case report. J Bone Joint Surg. 1984;66:142–143.
  • Lichtman EA. Candida infection of a prosthetic shoulder joint. Skeletal Radiol. 1983;10:176–177.
  • Goodman JS, Seibert DG, Reahl GE Jr, et al. Fungal infection of prosthetic joints: a report of two cases. J Rheumatol. 1983;10:494–495.
  • Wu MH, Hsu KY. Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer. Knee Surg Sports Traumatol Arthrosc. 2011;19:273–276.
  • Yang SH, Pao JL, Hang YS. Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty. 2001;16:529–532.
  • Lidder S, Tasleem A, Masterson S, et al. Candida tropicalis: diagnostic dilemmas for an unusual prosthetic hip infection. J R Army Med Corps. 2013;159:123–125.
  • Bruce ASW, Kerry RM, Norman P, et al. Fluconazole-impregnated beads in the management of fungal infection of prosthetic joints. J Bone Joint Surg Br. 2001;83:183–184.
  • Ramamohan N, Zeineh N, Grigoris P, et al. Candida glabrata infection after total hip arthroplasty. J Infect. 2001;42:74–76.
  • Selmon GP, Slater RN, Shepperd JA, et al. Successful 1-stage exchange total knee arthroplasty for fungal infection. J Arthroplasty. 1998;13:114–115.
  • Paul J, White SH, Nicholls KM, et al. Prosthetic joint infection due to Candida parapsilosis in the UK: case report and literature review. Eur J Clin Microbiol Infect Dis. 1992;11:847
  • Anagnostakos K, Kelm J, Schmitt E, et al. Fungal periprosthetic hip and knee joint infections. Clinical experience with a 2-stage treatment protocol. J Arthroplasty. 2012;27:293–298.
  • Artiaco S, Ferrero A, Boggio F, et al. Pseudotumor of the hip due to fungal prosthetic joint infection. Case Rep Orthop. 2013;2013:502728.
  • Bartalesi F, Fallani S, Salomoni E, et al. Candida glabrata prosthetic hip infection. Am J Orthop. 2012;41:500–505.
  • Lazzarini L, Manfrin V, De Lalla F. Candidal prosthetic hip infection in a patient with previous candidal septic arthritis. J Arthroplasty. 2004;19:248–252.
  • Dumaine V, Eyrolle L, Braixench MT, et al. Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents. 2008;31:398–399.
  • Merrer J, Dupont B, Nieszkowska A, et al. Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect. 2001;42:208–209.
  • Wada M, Baba H, Imura S. Prosthetic knee Candida parapsilosis infection. J Arthroplasty. 1998;13:479–482.
  • Fukasawa N, Shirakura K. Candida arthritis after total knee arthroplasty-a case of successful treatment without prosthesis removal. Acta Orthop Scand. 1997;68:306–307.
  • Zhu Y, Yue C, Huang Z, et al. Candida glabrata infection following total hip arthroplasty: a case report. Exp Ther Med. 2014;7:352–354.
  • Reddy KJ, Shah JD, Kale RV, et al. Fungal prosthetic joint infection after total knee arthroplasty. Indian J Orthop. 2013;47:526–529.
  • Lejko-Zupanc T, Mozina E, Vrevc F. Caspofungin as treatment for Candida glabrata hip infection. Int J Antimicrob Agents. 2005;25:272–277.
  • Fabry K, Verheyden F, Nelen G. Infection of a total knee prosthesis by Candida glabrata: a case report. Acta Orthop Belg. 2005;71:119–121.
  • Açkgöz ZC, Sayli U, Avci S, et al. An extremely uncommon infection: Candida glabrata arthritis after total knee arthroplasty. Scand J Infect Dis. 2002;34:394–396.
  • Marra F, Robbins GM, Masri BA, et al. Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candida albicans. Can J Surg. 2001;44:383–386.
  • Badrul B, Rusian G. Candida albicans infection of a prosthetic knee replacement: a case report. Med J Malaysia. 2000;55:93–96.
  • Nayeri F, Cameron R, Chryssanthou E, et al. Candida glabrata prosthesis infection following pyelonephritis and septicaemia. Scand J Infect Dis. 1997;29:635–638.
  • Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
  • Dale H, Fenstad AM, Hallan G, et al. Increasing risk of prosthetic joint infection after total hip arthroplasty. Acta Orthop. 2012;83:449–458.
  • Silva S, Henriques M, Martins A, et al. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009;47:681–689.
  • Davey ME, O’Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64:847–867.
  • Tsui C, Kong EF, Jabra-Rizk MA. Pathogenesis of Candida albicans biofilm. Pathog Dis. 2016;74:ftw018.
  • Kuhn DM, Chandra J, Mukherjee PK, et al. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002;70:878–888.
  • Pannanusorn S, Fernández V, Römling U. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection. Mycoses. 2013;56:264–272.
  • Silva S, Negri M, Henriques M, et al. Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol. 2011;19:241–247.
  • Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006;6:979–986.
  • Kim SJ, Huh J, Odrobina R, et al. Systemic review of published literature on Candida infection following total hip arthroplasty. Mycopathologia. 2015;179:173–185.
  • Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–25.
  • Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Work-group of the Musculoskeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994.
  • Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS collaborative study group. J Clin Microbiol. 1998;36:2932–2939.
  • Bémer P, Léger J, Tandé D, et al. How many samples and how many culture media to diagnose a prosthetic joint infection: a clinical and microbiological prospective multicenter study. J Clin Microbiol. 2016;54:385–391.
  • Peel TN, Dylla BL, Hughes JG, et al. Improved diagnosis of prosthetic joint infection by culturing periprosthetic tissue specimens in blood culture bottles. MBio. 2016;7:e01776-15. doi: 10.1128/mBio.01776-15.
  • Hughes JG, Vetter EA, Patel R, et al. Culture with BACTEC Peds Plus/F bottle compared with conventional methods for detection of bacteria in synovial fluid. J Clin Microbiol. 2001;39:4468–4471.
  • Berbari E, Mabry T, Tsaras G, et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am. 2010;92:2102–2109.
  • Austin MS, Ghanem E, Joshi A, et al. A simple, cost-effective screening protocol to rule-out periprosthetic infection. J Arthroplasty. 2008;23:65–68.
  • Goss B, Lutton C, Weinrauch P, et al. Elution and mechanical properties of antifungal bone cement. J Arthroplasty. 2007;22:902–908.
  • Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–535.
  • Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother. 2002;46:1773–1780.
  • Melo AS, Bizerra FC, Freymüller E, et al. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol. 2011;49:253–262.
  • Nogueira Gomes P, da Silva WJ, Cordeiro Pousa C, et al. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole. Arch Oral Biol. 2011;56:1274–1281.
  • Valentín A, Cantón E, Pemán J, et al. Actividad in vitro de la anfotericina B y la anidulafungina sobre biopelículas de Candida albicans y Candida tropicalis. Rev Iberoam Micol. 2007;24:272–277.
  • Valentín A, Cantón E, Pemán J, et al. Voriconazole inhibits biofilm formation in different species of the genus Candida. J Antimicrob Chemother. 2012;67:2418–2423.
  • Tobudic S, Kratzer C, Lassnigg A, et al. In vitro activity of antifungal combinations against Candida albicans biofilms. J Antimicrob Chemother. 2010;65:271–274.
  • Kuiper JW, van den Bekerom MP, van der Stappen J, et al. 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop. 2013;84:517–523.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.